Evonik Industries (FRA:EVK) has been assigned a €25.00 ($29.07) price target by analysts at Independent Research in a report issued on Wednesday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock. Independent Research’s price target indicates a potential upside of 12.92% from the company’s current price.
Other equities analysts also recently issued reports about the stock. HSBC set a €27.00 ($31.40) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a research note on Wednesday, May 29th. JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a research note on Thursday, August 1st. Credit Suisse Group set a €28.00 ($32.56) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a research note on Friday, April 12th. DZ Bank reaffirmed a “buy” rating on shares of Evonik Industries in a research note on Friday, June 14th. Finally, Kepler Capital Markets set a €25.00 ($29.07) price objective on shares of Evonik Industries and gave the company a “sell” rating in a research note on Tuesday, May 7th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of €30.54 ($35.51).
FRA EVK traded up €0.03 ($0.03) during trading on Wednesday, hitting €22.14 ($25.74). 743,130 shares of the company’s stock traded hands. The business’s fifty day moving average price is €25.37. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Article: What is the Dividend Aristocrat Index?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.